Bear of the Day: Houlihan Lokey (HLI)

Houlihan Lokey reported a Q4 revenue miss of 7% at $635.64 million versus $687.1 million consensus, while EPS missed by 11% at $1.63 versus $1.84 expected. Restructuring revenue fell 33% year over year to $110.4 million, and corporate finance and valuation advisory also came in below estimates, driving broad downward EPS revisions and a Zacks Rank #5 Strong Sell. Management’s cautious FY27 outlook adds to pressure, with the stock down nearly 20% over the last six months.

Analysis

The market is being told that this is not a one-off miss but a regime shift in the earnings power of a high-fixed-cost advisory platform. The key second-order issue is that HLI’s most profitable countercyclical engine is softening at the same time as its lower-margin core advisory franchises are also decelerating, which means EPS downside can persist even if headline revenue stabilizes. That combination is dangerous because it removes the usual cushion investors rely on when the cycle turns against boutiques.

The broader read-through is more important than the stock-specific call: if restructuring is not expanding despite elevated rates and geopolitical noise, then public-market distress is staying contained and sponsor-driven private solutions are still absorbing pain. That is negative for HLI, but it also argues that competitors with higher operating leverage and weaker brand equity may be even more vulnerable if M&A volumes fail to reaccelerate. For the ecosystem, this is an indirect warning on deal-adjacent names that trade on a recovery in transaction activity.

Near term, the risk is that estimate cuts continue for 1-2 quarters before management gets a clean catalyst to reset expectations. The bearish case can reverse only if restructuring mandates rebound or if large-cap M&A returns quickly enough to offset the mix drag; absent that, valuation support is fragile because the multiple still reflects a quality premium rather than a trough multiple. The contrarian angle is that the stock may already have discounted a lot of the slowdown, so a tactical bounce is possible if the next update merely confirms stabilization instead of another broad miss.

For now, the setup favors patience rather than value-calling. The most attractive risk/reward is not a naked short after a 20% drawdown, but a pair that expresses relative weakness versus a better-covered financial compounder or a short-dated put spread that benefits from another downward revision cycle without requiring a crash.

Key Decisions for Investors

• Short HLI on rallies into the next earnings-cycle revision window; target a 1-3 month horizon where estimate cuts can keep pressure on the multiple, with the main risk being a stabilization print that triggers a sharp relief bounce.
• Use a defined-risk bearish options structure on HLI, such as a 1-2 month put spread, to express continued downside from estimate compression while capping theta and avoiding open-ended short risk.
• Pair trade: long a higher-quality, more defensive capital-markets or financial compounder against short HLI for 2-4 months to isolate company-specific earnings revision risk from broad market beta.
• Avoid adding to long positions until the next quarterly cycle shows either restructuring normalization or better-than-expected advisory volumes; the setup is still more a 'show-me' story than a valuation opportunity.
• Set a trigger-based cover on the short if management commentary turns constructive or if restructuring revenue re-accelerates, since that would likely force a fast re-rating given the stock's still-premium multiple.